The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Although a humanized CCR4 antibody (mogamulizumab) was reported to be effective for refractory adult T-cell leukemia-lymphoma (ATL), several reports regarding the use of mogamulizumab before allo-hematopoietic stem cell transplantation (HSCT) strongly indicated a high incidence of severe acute graft...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Exp Hematop
Main Authors: Kawano, Noriaki, Kuriyama, Takuro, Yoshida, Shuro, Kawano, Sayaka, Yamano, Yoshihisa, Marutsuka, Kousuke, Minato, Seiichirou, Yamashita, Kiyoshi, Ochiai, Hidenobu, Shimoda, Kazuya, Ishikawa, Fumihiko, Kikuchi, Ikuo
Formato: Artigo
Idioma:Inglês
Publicado: JSLRT 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144179/
https://ncbi.nlm.nih.gov/pubmed/28331127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.135
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares